When Donna Seagrave was diagnosed with multiple sclerosis in the early 1990s, there were no approved disease-modifying drugs for the condition.
But a lot has changed over the past two decades. Seagrave, who recently started a new medication that enabled her to walk for the first time in 15 years, is a believer in the value of the research. She's participating in a clinical study, led by the University of New Mexico's Dr. Corey Ford, who is using powerful new neuroimaging technologies to better understand her disease and how to treat it more effectively.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?